SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-032173
Filing Date
2019-08-14
Accepted
2019-08-14 16:54:59
Documents
52
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20190630.htm 10-Q 1915705
2 EX-31.1 life-ex311_8.htm EX-31.1 9632
3 EX-31.2 life-ex312_9.htm EX-31.2 9131
4 EX-32.1 life-ex321_6.htm EX-32.1 5507
5 EX-32.2 life-ex322_7.htm EX-32.2 5496
  Complete submission text file 0001564590-19-032173.txt   6383911

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT life-20190630.xml EX-101.INS 1328463
7 XBRL TAXONOMY EXTENSION SCHEMA life-20190630.xsd EX-101.SCH 47820
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20190630_cal.xml EX-101.CAL 45620
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20190630_def.xml EX-101.DEF 205636
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20190630_lab.xml EX-101.LAB 383270
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20190630_pre.xml EX-101.PRE 300392
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 191027315
SIC: 2836 Biological Products, (No Diagnostic Substances)